Fundraising FoxVenrock — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease.
AI & Machine LearningBiotechHealthtechMedical Devices
Tassos Gianakakos(Co-Founder, Chief Executive Officer and Chair)inJay Edelberg, M.D., Ph.D.(Co-founder and Chief Medical Officer)inBob McDowell, Ph.D.(Co-Founder and Scientific Adviser)Leslie Leinwand, Ph.D.(Co-Founder)Beth McNally, M.D., Ph.D.(Co-Founder)
Co-investorsARCH Venture PartnersCatalio Capital Management, LPSequoia CapitalSequoia HeritageT. Rowe Price
Accompany was a relationship intelligence and business insights platform that has been acquired by Cisco and integrated into their collaboration products suite.
Enterprise SoftwareSaaS
Ryan McDonough(Founder)inAmy Chang(Founder)Matthias Ruhl(Founder)
Co-investorsCowboy VenturesCRV (Charles River Ventures)Vista Venture PartnersARCH Venture PartnersICONIQ CapitalIVP (Institutional Venture Partners)
Suki develops AI technology that assists clinicians with administrative tasks and documentation, enabling healthcare providers to focus more on patient care and clinical work.
AI & Machine LearningDigital HealthHealthtechRedwood City, US
Punit Singh Soni(Founder)inPunit Soni(Founder)
Co-investorsBreyer CapitalEpsilon Health InvestorsFirst Round CapitalFlare Capital PartnersGaingelsHealthier Capital+4 more
__Twitter.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.